KLRA
Kailera Therapeutics, Inc. Common Stock
NASDAQ: KLRA · HEALTHCARE · BIOTECHNOLOGY
$25.15
+0.60% today
Updated 2026-05-01
Market cap
$3.21B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.26
Dividend yield
—
52W range
$16 – $28
Volume
1.8M
Kailera Therapeutics, Inc. Common Stock (KLRA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2025 |
|---|---|
| Operating cash flow | $-120.21M |
| Capital expenditures | $2.09M |
| Depreciation | — |
| Stock-based comp | $10.94M |
| Free cash flow | $-122.30M |
| Investing cash flow | — |
| Financing cash flow | — |
| Dividends paid | — |
| Share repurchases | — |
| Debt repayment | — |
| Net change in cash | — |